Cargando…

31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935036/
http://dx.doi.org/10.1053/j.ajkd.2022.01.036
_version_ 1784671961105825792
collection PubMed
description
format Online
Article
Text
id pubmed-8935036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89350362022-03-21 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine Am J Kidney Dis Article Published by Elsevier Inc. 2022-04 2022-03-21 /pmc/articles/PMC8935036/ http://dx.doi.org/10.1053/j.ajkd.2022.01.036 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title_full 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title_fullStr 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title_full_unstemmed 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title_short 31 De Novo Class IV+V Lupus Nephritis After the BNT162b2 COVID-19 Vaccine
title_sort 31 de novo class iv+v lupus nephritis after the bnt162b2 covid-19 vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935036/
http://dx.doi.org/10.1053/j.ajkd.2022.01.036